High-potency marijuana impairs executive function and inhibitory motor control

Neuropsychopharmacology

Volumn 31, Issue 10, 2006, Pages 2296-2303

  Ramaekers, Johannes G ^a   Kauert, Gerhold ^b   Van Ruitenbeek, Peter ^a   Theunissen, Eef L ^a   Schneider, Erhard ^c   Moeller, Manfred R ^d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GOETHE UNIVERSITY   (Germany)

^c Landeskriminalamt   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

Author keywords

Acute; Cognition; Impulsivity; Motor control; Potency; THC

Indexed keywords

CANNABIS; PLACEBO; TETRAHYDROCANNABINOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; GAS CHROMATOGRAPHY; HUMAN; IMPULSIVENESS; MALE; MASS SPECTROMETRY; MOTOR CONTROL; PRIORITY JOURNAL; RESPONSE TIME; SINGLE DRUG DOSE; SMOKING; SOLID PHASE EXTRACTION; STATISTICAL ANALYSIS; TASK PERFORMANCE;

ADULT; CHOICE BEHAVIOR; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HALLUCINOGENS; HUMANS; MALE; MARIJUANA SMOKING; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TETRAHYDROCANNABINOL; TIME FACTORS;

EID: 33748800982     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301068     Document Type: Article

References (45)

1. Ameri A (1999). The effects of cannabinoids on the brain. Prog Neurobiol 58: 315-348.
2. Bechara A, Damasio H, Damasio AR (2000). Emotion, decision making and the orbitofrontal cortex. Cereb Cortex 10: 295-307.
3. Bechara A, Dolan S, Denburg N, Hindes A, Anderson SW, Nathan PE (2001). Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39: 376-389.
4. Bolla KI, Eldreth DA, Matochik JA, Cadet JL (2005). Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26: 480-492.
5. Chait LD (1989). Delta-9-tetrahydrocannabinol content and human marijuana self-administration. Psychopharmacology (Berl) 98: 51-55.
6. Chait LD, Burke KA (1994). Preference for high- versus low-potency marijuana. Pharmacol Biochem Behav 49: 643-647.
7. Curran HV, Brignell C, Fletcher S, Middleton P, Henry J (2002). Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) 164: 61-70.
8. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT et al (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558-1572.
9. ElSohly MA (2004). Marijuana potency monitoring project. National Center for Natural Products Research, School of Pharmacy, University of Mississippi.
10. Fant RV, Heishman SJ, Bunker EB, Pickworth WB (1998). Acute and residual effects of marijuana in humans. Pharmacol Biochem Behav 60: 777-784.
11. Fillmore MT, Rush CR, Hays L (2002). Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug Alcohol Depend 67: 157-167.
12. Fried PA, Watkinson B, Gray R (2005). Neurocognitive consequences of marihuana-a comparison with pre-drug performance. Neurotoxicol Teratol 27: 231-239.
13. Grant S, Contoreggi C, London ED (2000). Drug abusers show impaired performance in a laboratory test of decision making. Neuropsychologia 38: 1180-1187.
14. Hall W, Solowij N (1998). Adverse effects of cannabis. Lancet 352: 1611-1616.
15. Hampson RE, Deadwyler SA (1999). Cannabinoids, hippocampal function and memory. Life Sci 65: 715-723.
16. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW (1999). Abstinence symptoms following smoked marijuana in humans. Psychopharmacology (Berl) 141: 395-404.
17. Hart CL, van Gorp W, Haney M, Foltin RW, Fischman MW (2001). Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25: 757-765.
18. Heishman SJ, Arasteh K, Stitzer ML (1997). Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav 58: 93-101.
19. Iversen L (2003). Cannabis and the brain. Brain 126: 1252-1270.
20. Jex HR, McDonnell JD, Phatak AV (1966). A 'critical'tracking task for manual control research. IEEE 7: 138-145.
21. King LA, Carpentier C, Griffiths P (2004). An Overview of Cannabis Potency in Europe. European Monitoring Centre for Drugs and Drug Addiction: Lisbon.
22. King LA, Carpentier C, Griffiths P (2005). Cannabis potency in Europe. Addiction 100: 884-886.
23. Korf DJ, Wouters M, Benschop A, Van Ginkel P (2004). Sterke Wiet. Criminologisch Instituut Bongers, University of Amsterdam, Rozenberg Publishers: Amsterdam.
24. Lamers CTJ, Bechara A, Rizzo M, Ramaekers JG (2005). Cognitive function and mood in MDMA/THC users, THC users and nondrug using controls. J Psychopharmacol 20: 302-311.
25. Lane SD, Cherek DR, Tcheremissine OV, Lieving LM, Pietras CJ (2005). Acute marijuana effects on human risk taking. Neuropsychopharmacology 30: 800-809.
26. Leweke M, Kampmann C, Radwan M, Dietrich DE, Johannes S, Emrich HM et al (1998). The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials. Neuropsychobiology 37: 104-111.
27. Lichtman AH, Varvel SA, Martin BR (2002). Endocannabinoids in cognition and dependence. Prostaglandins Leukot Essent Fatty Acids 66: 269-285.
28. Liguori A, Gatto CP, Jarrett DB (2002). Separate and combined effects of marijuana and alcohol on mood, equilibrium and simulated driving. Psychopharmacology (Berl) 163: 399-405.
29. Liguori A, Gatto CP, Jarrett DB, McCall WV, Brown TW (2003). Behavioral and subjective effects of marijuana following partial sleep deprivation. Drug Alcohol Depend 70: 233-240.
30. Logan GD, Cowan WB, Davis KA (1984). On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform 10: 276-291.
31. Logan GDI (1994). On the ability to inhibit though and action: a users' guide to the stop signal paradigm. In: Dagenbach D, Carr TH (eds). Inhibitory Processes in Attention, Memory and Language. Academic Press: San Diego. pp 189-239.
32. McDonald J, Schleifer L, Richards JB, de Wit H (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28: 1356-1365.
33. Monterosso J, Ehrman R, Napier KL, O'Brien CP, Childress AR (2001). Three decision-making tasks in cocaine-dependent patients: do they measure the same construct? Addiction 96: 1825-1837.
34. Nicholson AN, Turner C, Stone BM, Robson PJ (2004). Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol 24: 305-313.
35. Pope Jr HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D (2001). Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 58: 909-915.
36. Ramaekers JG (2003). Antidepressants and driver impairment: empirical evidence from a standard on-the-road test. J Clin Psychiatry 64: 20-29.
37. Ramaekers JG, Berghaus G, van Laar M, Drummer OH (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 73: 109-119.
38. Ramaekers JG, Kuypers KP (2006). Acute Effects of 3,4- Methylenedioxymethamphetamine (MDMA) on Behavioral Measures of Impulsivity: Alone and in Combination with Alcohol. Neuropsychopharmacology 31: 1048-1055.
39. Ramaekers JG, Robbe HW, O'Hanlon JF (2000). Marijuana, alcohol and actual driving performance. Hum Psychopharmacol 15: 551-558.
40. Robbe HWJ (1994). Influence of Marijuana on Driving. Institute for Human Psychopharmacology, University of Limburg.
41. Sexton BF, Turnbridge RJ, Brook-Carter N, Jackson PG, Wright KA, Strak MM et al (2000). The Influence of Cannabis on Driving. Transport Research Foundation Limited (TRL): United Kingdom.
42. Shallice T (1982). Specific Impairments of Planning. Phil. Trans. of the Royal Society of London: London. pp 199-209.
43. Smiley A (1999). On road and driving simulator studies. In: Kalant H, Corrigal W, Hall W, Smart R (eds). The Health Effects of Cannabis. Addiction Research Foundation: Toronto.
44. Steinmeyer S, Bregel D, Warth S, Kraemer T, Moeller MR (2002). Improved and validated method for the determination of Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy-THC in serum, and in human liver microsomal preparations using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 772: 239-248.
45. Veale DM, Sahakian BJ, Owen AM, Marks IM (1996). Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive-compulsive disorder. Psychol Med 26: 1261-1269.